Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF MAY 21, 2022 SAM #7477
SOURCES SOUGHT

65 -- Sources Sought Notice - Cost-Per-Test - Reagents for BCR-ABL Tests

Notice Date
5/19/2022 7:29:17 AM
 
Notice Type
Sources Sought
 
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
 
Contracting Office
W40M USA HLTH CONTRACTING ACT JBSA FT SAM HOUSTON TX 78234-0000 USA
 
ZIP Code
78234-0000
 
Solicitation Number
W81K00-22-Q-0112
 
Response Due
5/26/2022 11:00:00 AM
 
Point of Contact
Medina L. Woodson, Phone: 2105398525, Fax: 2102213446, Randall P. Cummins, Phone: (719) 526-5329, Fax: 719-524-5405
 
E-Mail Address
medina.l.woodson.civ@mail.mil, randall.p.cummins.civ@mail.mil
(medina.l.woodson.civ@mail.mil, randall.p.cummins.civ@mail.mil)
 
Description
� � � � � � � � � � � � � � � � � � � �Sources Sought Notice � Cost-Per-Test - Reagents for BCR-ABL Tests �The Regional Health Contracting Office - Central is issuing this Sources Sought Notice on behalf of San Antonio Military Medical Center, JBSA - Fort Sam Houston, Texas. Any responses to this Sources Sought Notice will be used for planning purposes only. This notice is not a solicitation of binding offers, nor is it a notice to proceed. The San Antonio Military Medical Center (SAMMC) has a requirement for a Cost-Per-Test Agreement to include to include reagents, consumables, controls, supplies, training and maintenance service to conduct BCR-ABL testing at the Brooke Army Medical Center (BAMC) in Fort Sam Houston TX. The QuantideX qPCR BCR-ABL IS Kit is FDA-cleared for the ultra-sensitive detection and precise monitoring of BCR-ABL1 transcripts resulting from the Major breakpoints (e13a2, e14a2). The QuantideX qPCR BCR-ABL minor Kit is a clinical research tool enabling ultra-sensitive and precise detection of BCR-ABL1 minor fusion transcripts (e1a2) from whole blood specimens. These real-time Polymerase Chain Reaction (PCR) assays are designed to run on the Applied Biosystems 7500 Fast Dx Real-Time PCR Instruments. The instrument is controlled by an external computer with SDS Software. By rapidly quantifying BCR-ABL translocations, the clinicians can order tests, make referrals, and treat as appropriate, thus saving time, eliminating unnecessary costs, and providing best patient care to soldiers and their beneficiaries to maintain a state of physical and mental health readiness. Vendors that consider themselves capable of providing the required testing are invited to submit a capability statement for the Government to consider via email to the Point of Contact listed herein. This capability statement shall include the following information. If the capability statement does not address ALL of the points below, the vendor will not be considered as capable of providing the required testing: Vendor name (to include CAGE code and DUNS number); Point of Contact (to include email address and phone number); business size. Documentation that demonstrates its ability to provide Cost-Per-Test Agreement to include reagents instrument/equipment, consumables, controls, and any necessary services (e.g., maintenance of furnished equipment) to conduct testing to include: CDC Basic panel, Leukemia/Lymphoma, and Stem Cell/CD34. Food and Drug Administration (FDA) approval if applicable. Capability Statement (limited to ten pages), describing how your company meets the below objectives, providing additional proof (such as FDA approval) where appropriate: Basic Requirements:� - Provide consumable reagents for the operation of select quantitative BCR-ABL reagents.�� - Provides reagents and controls for translocation assays: - Quantitative BCR-ABL of major fusion transcripts (e13a2, e14a2) and minor fusion transcripts (e1a2) - All reagents for each assay must be FDA approved to provide quantitative BCR-ABL results on the international scale and Include In-run IS calibrators - Ensures proper of cold-chain management of supply during shipping - Offers overnight shipping when requested - Orders are processed and received at facility no more than 5 days after order placement, excluding weekends and federal holidays - Ensures no cost replacement of supplies if damaged or out of temperature upon arrival as determined by end user. -� Ensures reagents expiration date is at least six months or more from received date. - Provides direct customer service during normal business hours, excluding weekends and holidays - Provides recall or advisory information within 2 days of notice to end user. - All reagents must be FDA Approved for the 7500 Fast DX - Turnaround time is 5 hours or less ���
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/b3ee0f86435c40c48ed2ad92e97099c6/view)
 
Place of Performance
Address: JBSA Ft Sam Houston, TX 78234, USA
Zip Code: 78234
Country: USA
 
Record
SN06333304-F 20220521/220519230105 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.